Original Source(s)
Related Content
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
Dalbavancin Exposure Linked to Higher Success in Bacteremia
Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory
May 6, 2026
-
4 min
Inside Pathology’s New Audio Drama
Case Encounters reimagines real diagnostic cases as podcast stories to highlight how pathologists solve clinical mysteries
April 14, 2026
-
9 min